Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Leap Therapeutics Inc (LPTX)
NASDAQ:LPTX
Holding LPTX?
Track your performance easily
See the Price Targets and Ratings of:
LPTX Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LPTX Stock 12 Month Forecast
Average Price Target
$5.50
▲(113.18% Upside)
| Highest Price Target$5.50 | Average Price Target$5.50 | Lowest Price Target$5.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
11/15/24
Robert W. Baird
$9
Buy
248.84%
Upside
Reiterated
08/12/24
Optimistic Buy Rating on Leap Therapeutics Amid Promising Phase 2 Cancer Trial Outcomes
Rodman & Renshaw
$8
Buy
210.08%
Upside
Initiated
06/28/24
Leap Therapeutics initiated with a Buy at Rodman & RenshawLeap Therapeutics initiated with a Buy at Rodman & Renshaw
Piper Sandler
$21→$15
Buy
481.40%
Upside
Reiterated
03/18/24
Leap Therapeutics (LPTX) PT Lowered to $15 at Piper SandlerPiper Sandler analyst Joseph Catanzaro lowered the price target on Leap Therapeutics (NASDAQ: LPTX) to $15.00 (from $21.00) while maintaining a Overweight rating.
Mizuho Securities
$12
Buy
365.12%
Upside
Reiterated
01/23/24
Maintaining Buy Rating on Leap Therapeutics: Promising DKN-01 Trials and Undervalued Market Potential
Best Analysts Covering Leap Therapeutics
Which Analyst Should I Follow If I Want to Buy LPTX and Sell After:
1 Month
xxx
Success Rate
8/13 ratings generated profit
Average Return
+8.58%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 61.54% of your transactions generating a profit, with an average return of +8.58% per trade.
3 Months
xxx
Success Rate
5/13 ratings generated profit
Average Return
+0.17%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 38.46% of your transactions generating a profit, with an average return of +0.17% per trade.
1 Year
Success Rate
3/13 ratings generated profit
Average Return
-15.82%
reiterated a buy rating 7 days ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 23.08% of your transactions generating a profit, with an average return of -15.82% per trade.
2 Years
xxx
Success Rate
4/13 ratings generated profit
Average Return
-19.46%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 30.77% of your transactions generating a profit, with an average return of -19.46% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LPTX Analyst Recommendation Trends
Rating
Mar 24
May 24
Jun 24
Aug 24
Nov 24
Strong Buy
12
13
6
5
4
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
13
6
5
4
Each month's total comprises the sum of three months' worth of ratings.
LPTX Financial Forecast
LPTX Stock Forecast FAQ
What is LPTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Leap Therapeutics Inc’s 12-month average price target is $5.50.
What is LPTX’s upside potential, based on the analysts’ average price target?
Leap Therapeutics Inc has 113.18% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LPTX a Buy, Sell or Hold?
Leap Therapeutics Inc has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Leap Therapeutics Inc’s price target?
The average price target for Leap Therapeutics Inc is $5.50. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $5.50 ,the lowest forecast is $5.50. The average price target represents 113.18% Increase from the current price of $2.58.
The highest analyst price target is $5.50 ,the lowest forecast is $5.50. The average price target represents 113.18% Increase from the current price of $2.58.
What do analysts say about Leap Therapeutics Inc?
Leap Therapeutics Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of LPTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.